Dimitrios Kapogiannis is a graduate of the University of Athens Medical School. He completed his Neurology Residency training at Massachusetts General Hospital/Harvard Medical School and a Clinical Fellowship in Behavioral Neurology at the National Institute of Neurological Disorders and Stroke. He is a Clinical Investigator at the Laboratory of Neurosciences at the National Institute on Aging conducting clinical and translational studies in Alzheimer's disease. His primary focus is on Extracellular Vesicles as a source of biomarkers and as effectors in neurodegenerative diseases pathogenesis. He is also conducting clinical trials of metabolism-based interventions for Alzheimer’s disease prevention and treatment. He holds an adjunct appointment as Associate Professor at the Department of Neurology of Johns Hopkins University and providing clinical care as attending at the Johns Hopkins Memory and Alzheimer's Treatment Center. Dr. Kapogiannis has authored more than 60 peer-reviewed publications. He is also member of the Editorial Boards of "Ageing Research Reviews" and "npj Aging and Mechanisms of Disease". Dr. Kapogiannis is considered an expert on isolating neuronal-origin Extracellular Vesicles from peripheral blood as a source of biomarkers for neurological disorders.